About this Sofwave reference

Gangnam Sofwave is a single-platform editorial reference focused exclusively on Sofwave Synchronous Ultrasound Parallel Beam (SUPERB) technology as it is practiced in Gangnam, Seoul. The archive is edited from Singapore by Priya Tan, an aesthetic editor working across the ASEAN region, and is operated as part of the HEIM GLOBAL publisher network registered with the Korea Health Industry Development Institute (KHIDI A-2026-04-02-06873). The editorial perspective here is intentionally global-comparative: Sofwave is an Israeli-developed platform that received its initial United States FDA clearance in 2019, contrasted with Korean-deployed micro-focused ultrasound platforms such as Ultherapy, and the editorial brief is to give Singapore, Hong Kong, Taiwan, and Japan readers an honest read on where Sofwave fits in a non-surgical lifting programme. Coverage is general orientation rather than clinical recommendation; clinical decisions belong with the treating physician.

Editorial scope and what this archive does not do

The Gangnam Sofwave archive covers a single platform — Sofwave SUPERB — as deployed in Gangnam-area Korean clinics. It is not a clinic-listing directory and does not rank clinics by alphanumeric position. Where editorial coverage references named providers, inclusion is editorial-pick rather than commercial ranking, and outbound links to clinic websites carry rel="sponsored noopener" where commercial relationships exist. The archive does not publish before-and-after photography sourced from third parties without manufacturer or clinic permission, does not republish clinical trial imagery without attribution to the originating publication, and does not make therapeutic claims beyond the cleared indications listed by Sofwave Medical and validated by the Korean Ministry of Food and Drug Safety. The editorial line is comparative — Sofwave versus Ultherapy, versus radiofrequency platforms, versus regenerative bio-actives — and pricing-transparent. Patients who require platform-agnostic guidance across the full non-surgical lifting category should consult the broader the Korea medical-tourism directory reference operated by the same publisher group.

About the editor — Priya Tan, Singapore

Priya Tan is an aesthetic editor based in Singapore covering the Korean medical-tourism market for ASEAN-region readers. Her editorial brief on this archive is to interpret Sofwave clinical literature and Korean clinical-practice patterns through a Southeast-Asian patient lens — accounting for ASEAN-region skin types (Fitzpatrick III to V), the prevalence of Sofwave alternatives in Singapore and Hong Kong markets, and the practical realities of a four-to-seven-day Seoul trip from a regional hub. She works without commercial commission from individual clinics. The editorial process involves cross-checking clinic claims against the Sofwave Medical authorised-provider directory, reviewing peer-reviewed clinical trial publications listed on the manufacturer's clinical-evidence page, and consulting with Korean-resident editors at the parent network for in-market context. Reader correspondence on factual matters can reach the editor through the parent network contact form.

How we handle commercial relationships

The publisher operates a small network of single-platform archives — Sofwave, Ultherapy, Thermage, regenerative-medicine, and others — each focused on platform-level editorial coverage. Where a clinic that the editorial team has covered chooses to participate in the wider HEIM GLOBAL medical-tourism facilitation programme, that relationship is disclosed at the article level, the outbound link is marked rel="sponsored noopener" per Google's Webmaster Guidelines, and editorial coverage is not contingent on the commercial relationship. Editorial-pick clinics may or may not have a commercial relationship; many do not. The archive does not publish promotional copy ghost-written by clinics, does not publish at-cost-or-below comparison content commissioned by individual clinics, and does not use ranking language (#1, top-rated, best-in-Gangnam) that would imply a commercial league table. The honest answer to the question 'is this a sponsored archive' is: the network is commercial, individual coverage is editorial, and the disclosure block at the foot of every article makes this explicit.

How to read coverage from this archive

Singapore, Hong Kong, Taiwan, and Japan readers have a particular reading style for Korean medical-tourism coverage: skim for platform authenticity, check for honest pricing, look for downside disclosure, then evaluate whether the editorial voice matches the reader's risk tolerance. The Gangnam Sofwave archive is written for that reading style. Each article opens with a one-paragraph orientation statement, moves to a comparative frame against named alternative platforms, lays out Korean pricing context with multi-currency conversions, addresses tolerability and downtime honestly, and closes with a candidacy-and-not-for-this-platform discussion. The FAQ blocks are designed to answer the questions that come up in pre-trip planning — flight timing, consultation-to-treatment turnaround, multi-modality combinations, post-treatment travel windows. The archive is published in English; Mandarin, Cantonese, and Japanese readers are welcome to use machine translation, with the caveat that medical terminology requires careful handling. The editorial team welcomes correction notes on specific clinical points and updates the archive against new clinical literature on a quarterly basis. For readers comparing Sofwave with focused-ultrasound alternatives, the Ultherapy editorial archive covers that platform in parallel format.

Editorial board

This archive is published under the editorial board operated by Gangnam Meditour, a Korea medical-tourism directory registered with KHIDI under A-2026-04-02-06873. Editorial decisions are made by named contributing editors who also write for our specialised treatment archives.

Frequently asked questions

Is Gangnam Sofwave a clinic, a publisher, or a directory?

It is a single-platform editorial reference — published by HEIM GLOBAL, not operated by a clinic. We do not deliver Sofwave treatments, we cover Sofwave editorially. Coverage is general orientation rather than clinical recommendation.

Why is the archive edited from Singapore rather than Seoul?

The brief is to write for international patients — primarily Singapore, Hong Kong, Taiwan, and Japan readers — who are evaluating Sofwave in Korea against alternatives in their home markets. A Singapore editorial perspective gives the global-comparative frame that a Seoul-only editor would not naturally adopt. Korean-resident editors at the parent network provide in-market context.

Do you take commission from clinics for editorial coverage?

Editorial inclusion is independent of commercial relationships. Where commercial relationships exist they are disclosed and outbound links carry rel="sponsored noopener". Editorial-pick clinics are chosen on platform authenticity, physician seniority, and patient-experience signals — not on commission rates.

How current is the clinical literature you reference?

We refresh the archive on a quarterly basis against new peer-reviewed publications in Lasers in Surgery and Medicine, the Journal of Cosmetic Dermatology, and similar venues, plus Sofwave Medical's published clinical-evidence updates. Clinical claims are dated and the editorial team annotates substantive updates.

Why do you focus on Sofwave specifically rather than the full lifting category?

Single-platform depth lets us do the comparative frame properly — comparing Sofwave against Ultherapy, against Thermage, against radiofrequency-microneedling devices, with the clinical detail that a generalist directory cannot accommodate. Readers who want platform-agnostic guidance can use the broader HEIM GLOBAL reference.

Can I book Sofwave through this archive?

We do not handle bookings directly. Where a clinic offers Sofwave and chooses to participate in the HEIM GLOBAL medical-tourism programme, the parent network handles facilitation. Most readers prefer to contact clinics directly with the editorial context this archive provides; that is also a reasonable path.

Is the editor open to clinical-correction notes?

Yes. The editorial team treats clinical accuracy as a higher priority than narrative continuity and welcomes correction notes from physicians, clinical researchers, and informed patients. Substantive corrections are applied within seven days and the article footer notes the update.

Are you affiliated with Sofwave Medical, the manufacturer?

No. We have no commercial or editorial relationship with Sofwave Medical. The archive references the manufacturer's authorised-provider directory and clinical-evidence publications as primary sources, but operates independently of the company. Manufacturer correspondence is welcomed and treated as a primary-source input rather than editorial direction.